Prostate cancer is caused by elevated hormone levels, and tumors are generally treated using hormone therapy. However, after some time, tumor growth is no longer dependent on hormones, which results in resistance to treatment. ...
Nov 18, 2020
0
7
A preclinical study conducted at the Institute of Oncology Research (IOR, affiliated to USI Università dellaSvizzera italiana) reveals the role of aging cells in the formation of metastases and identifies a drug capable ...
Nov 13, 2020
0
122
Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.
Nov 27, 2019
0
5
Scientists have identified a gene mutation in the tumours of men with prostate cancer that is linked to very poor survival—and which could be used to pick out patients for more intensive treatment.
May 6, 2019
0
49
A new 'seek-and-destroy' gene therapeutic system could have the potential to treat prostate cancer in the future, after it halted the majority of tumours in laboratory models at the University of Strathclyde and the Beatson ...
Feb 4, 2019
0
0
Unlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despite being a well-known cause of therapy resistance and metastasis, ...
Jan 14, 2019
0
32
The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated via two therapies: taxanes or hormone treatment. Until recently, there were no comparative studies between the two, and the ...
Nov 14, 2018
0
6
A group of men with especially aggressive prostate cancer may respond unusually well to immunotherapy, a major new study reports.
Sep 5, 2018
0
12
A technique using live human cancer tissue to develop the next generation of cancer drugs is being developed in South Australia.
Aug 22, 2018
0
29
A team of scientists and clinicians have developed a faster and more accurate way to test new treatments for the most aggressive form of prostate cancer.
Jul 25, 2018
0
2
